121 related articles for article (PubMed ID: 4293436)
1. [On the production of monovalent foot-and-mouth disease vaccine concentrate from tissue culture virus type O].
Mitev G; Wassilewa L; Tekerlekov P
Arch Exp Veterinarmed; 1966 Mar; 20(1):85-90. PubMed ID: 4293436
[No Abstract] [Full Text] [Related]
2. [Cultivation of foot-and-mouth disease virus type O in tissue cultures and utilization of its mutability for the production of new vaccine strains].
Mitev G; Tekerlekov P
Arch Exp Veterinarmed; 1966 Mar; 20(1):91-7. PubMed ID: 4293437
[No Abstract] [Full Text] [Related]
3. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
Hyslop NS; Morrow AW
Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
[No Abstract] [Full Text] [Related]
4. [Studies on the suitability of tissue culture neutralization tests in the government etesting of adsorbed foot-and mouth disease vaccines. 1. The content of neutralizing antibody in the serum of cattle after vaccination with adsorbed vaccine against type O2 virus in comparison with the direct immunity testing in cattle].
Rüting E; Seils H; Weyhe D; Benndorf E
Arch Exp Veterinarmed; 1969; 23(4):827-38. PubMed ID: 4319494
[No Abstract] [Full Text] [Related]
5. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
[TBL] [Abstract][Full Text] [Related]
6. Proceedings: Quantitative assay of the immunizing dose of monovalent vaccines against foot-and-mouth disease prepared from the virus propagated on cattle tongue mucosa and in culture after Frenkel.
Wiśniewski J; Kobusiewicz T; Szkilnik S; Baranowski C; Jankowska J; Labecka W
Acta Microbiol Pol A; 1974; 6(1):131. PubMed ID: 4364054
[No Abstract] [Full Text] [Related]
7. [Preparation and testing of an anti-aphthous vaccine with A22 virus cultured in tissue cultures].
Orlov SD; Bykov IA; Ratner LS; Moutouzkina ZP; Ignatieva VS
Bull Off Int Epizoot; 1969; 71(3-4):393-5. PubMed ID: 4323527
[No Abstract] [Full Text] [Related]
8. [On the immunizing properties of GOAL-formol vaccine and GNKI dry virus vaccine against foot-and-mouth disease].
Lazarev PS; Amelin IP; Zaslonov MS
Veterinariia; 1966 Sep; 43(9):30-1. PubMed ID: 6011469
[No Abstract] [Full Text] [Related]
9. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
Warrington RE; Cunliffe HR; Bachrach HL
Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
[No Abstract] [Full Text] [Related]
10. Immunological studies with cell cultured aluminium hydroxide gel adsorbed formalin inactivated foot and mouth disease type Asia I monovalent vaccine.
Negi BS; Kumar S
Indian Vet J; 1970 Jul; 47(7):555-61. PubMed ID: 4318813
[No Abstract] [Full Text] [Related]
11. Studies on the immune response of foot-and-mouth disease vaccine type Asia-1 in pregnant ewes, lambs and evaluation of type O vaccine by challenge.
Nair SP; Sen AK
Acta Virol; 1994 Oct; 38(5):257-61. PubMed ID: 7725999
[TBL] [Abstract][Full Text] [Related]
12. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
Sen AK; Saha SN
Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
[TBL] [Abstract][Full Text] [Related]
13. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
Dunn CS; Samuel AR; Pullen LA; Anderson J
Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
[TBL] [Abstract][Full Text] [Related]
14. [Trials of vaccination ff swine against foot-and-mouth disease virus type O with a live vaccine obtained through mouse brain passage].
Benndorf E
Arch Exp Veterinarmed; 1966 Mar; 20(1):151-6. PubMed ID: 4293435
[No Abstract] [Full Text] [Related]
15. [Testing the activity of anti-foot-and-mouth disease aluminum hydroxide formol vaccine on guinea pigs].
Kuleshova LA; Kozlovskiĭ GA; Sorvachev EV; Murashkin VI
Veterinariia; 1969 May; 5():25-7. PubMed ID: 5381315
[No Abstract] [Full Text] [Related]
16. Storage-related potency changes in monovalent type O1, A5 and C foot-and-mouth disease vaccine preparations.
Sólyom F; Fazekas A; Czelleng F
Acta Vet Acad Sci Hung; 1981; 28(3):289-95. PubMed ID: 6266237
[No Abstract] [Full Text] [Related]
17. Early response of cattle and swine to inactivated foot-and-mouth disease vaccine.
Graves JH; McKercher PD; Farris HE; Cowan KM
Res Vet Sci; 1968 Jan; 9(1):35-40. PubMed ID: 5689040
[No Abstract] [Full Text] [Related]
18. [Possibilities and limits of immunochemical methods (radio- and enzyme immunoassay) in testing foot-and-mouth disease vaccine].
Schilow WF; Reimann I
Arch Exp Veterinarmed; 1984 Sep; 38(5):697-703. PubMed ID: 6099107
[No Abstract] [Full Text] [Related]
19. [Specific immunoprophylaxis trials with calves against foot-and-mouth disease].
Tekerlekov P; Uruchev K; Nikolova E; Genov I; Tsutsumanski V
Vet Med Nauki; 1980; 17(2):28-35. PubMed ID: 6254238
[TBL] [Abstract][Full Text] [Related]
20. Basis of the preparation of A22 type foot-and-mouth disease vaccine in Turkey.
Okay G; Sutcu M; Bayramoglu O; Oral M; Unluleblebici N; Senturk M; Girard HC
Bull Off Int Epizoot; 1969; 71(3-4):341-50. PubMed ID: 4323524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
